Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106966901B enables green synthesis of lipoic acid intermediates with boron recycling. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113185485A reveals a novel thiourea dioxide reduction method for dihydroquercetin, offering significant cost reduction and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN106282134A details KgQR enzyme for high yield synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN102876734B details a novel carbonyl reductase for high-purity chiral alcohol production, offering significant cost and supply chain advantages for API intermediates.
Patent CN103555608B reveals high-efficiency biocatalytic route for chiral intermediate. Enables cost reduction and supply chain reliability for pharma.
Patent CN1376659A reveals a safe metal borohydride reduction system for high-purity chiral intermediates, offering significant cost and supply chain advantages.
Patent CN102993102A reveals a safer synthetic route for NL-101, an HDAC inhibitor intermediate, replacing toxic ethylene oxide with chloroacetic acid for cost-effective manufacturing.
Patent CN103709095B reveals sodium disulfide reduction for high-purity API intermediate manufacturing with significant cost and supply chain advantages.
Patent CN117210426A reveals enzyme mutant for chiral alcohol synthesis. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediate supplier solutions.
Novel enzymatic route for Darunavir intermediate (3R, 3aS, 6aR)-hexahydrofuro[2,3-b]furan-3-ol offering high optical purity and industrial scalability.
Advanced flow synthesis for Crizotinib intermediates reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally seeking scalable solutions.
Patent CN119409702B reveals a safer synthesis route for dipyridamole intermediates. Achieve high purity and supply chain stability with advanced catalytic methods.
Patent CN115536720A details a novel chemical synthesis for cholic acid intermediate A8, offering a virus-free, plant-based alternative to animal extraction with scalable manufacturing potential.
Patent CN106518850A details a safer Pimobendan synthesis route. Discover cost-effective manufacturing and reliable supply chain solutions for veterinary pharmaceuticals.
Patent CN103570699A reveals a high-yield synthesis for prucalopride intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN110804051B reveals a mild, high-yield route for 3-alpha-homotropylamine. Discover cost-effective manufacturing and supply chain advantages.
Patent CN115010193A reveals a silver-free route for tetraammine platinum salts. Achieve >99% purity and reduced costs for industrial catalyst manufacturing.
Patent CN112899246B details novel KmAKR mutants for synthesizing chiral statin side chains with superior stability and stereoselectivity for API manufacturing.
Patent CN106754775B details ScCR1 mutants for Atorvastatin intermediate. Offers high stability and activity for cost-effective manufacturing.
Patent CN111575334B reveals a stable immobilized enzyme method for synthesizing chiral alcohols, offering significant cost reduction and supply reliability for API manufacturing.